Physician profile
Kellie Grove
NPI 1811472681
$8,510.88
in general payments reported to CMS, 2019-2025
33 companies · $3,226 in 2025
The $3,226 reported for 2025 was more than what 98% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $478 · 2022: $624 · 2023: $1,615 · 2024: $2,568 · 2025: $3,226.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,398 · Education: $10.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,398.01 |
| Education | $10.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,563.69 | 2021-2025 | Fasenra, Breztri, Airsupra |
| Glaxosmithkline, LLC. | $1,508.08 | 2021-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $856.49 | 2021-2025 | Ofev, Jascayd |
| Harmony Biosciences LLC | $469.02 | 2023-2025 | Wakix |
| Merck Sharp & Dohme LLC | $467.52 | 2022-2025 | Zerbaxa, Recarbrio, Winrevair |
| Genzyme Corporation | $402.86 | 2021-2025 | |
| Jazz Pharmaceuticals INC. | $391.54 | 2021-2025 | Xywav |
| Regeneron Healthcare Solutions, INC. | $383.22 | 2021-2025 | Dupixent |
| Mallinckrodt Hospital Products INC. | $314.73 | 2021-2025 | Acthar |
| Inspire Medical Systems, INC. | $301.02 | 2023-2024 | Inspire |
| Novartis Pharmaceuticals Corporation | $214.85 | 2021-2024 | |
| Ani Pharmaceuticals, INC. | $157.02 | 2023-2025 | Purified Cortrophin Gel |
| Electromed, INC. | $154.51 | 2024-2025 | Smartvest |
| Mylan Specialty L.P. | $151.86 | 2021-2024 | Yupelri |
| Takeda Pharmaceuticals U.S.A., INC. | $141.82 | 2021-2025 | Glassia |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| United Therapeutics Corporation | $135.70 | 2021-2025 | Tyvaso, Tyvaso |
| Amgen INC. | $130.65 | 2023-2025 | Tezspire |
| Grifols USA, LLC | $115.06 | 2025 | Prolastin-C Liquid |
| Pulmonx Corporation | $108.19 | 2023-2025 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Chartis Catheter |
| Verona Pharma, INC. | $83.36 | 2025 | Ohtuvayre |
| Viatris Specialty LLC | $81.15 | 2025 | Yupelri |
| Insmed, INC. | $51.96 | 2023-2025 | Arikayce, Brinsupri |
| La Jolla Pharmaceutical Company | $46.54 | 2024-2025 | Giapreza |
| Baxter Healthcare | $44.98 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Genentech USA, INC. | $43.32 | 2025 | Xolair |
| Actelion Pharmaceuticals US, INC. | $40.48 | 2025 | Opsynvi, Uptravi, Opsumit |
| Philips North America LLC | $35.00 | 2024 | (Ak6) Vest Therapy |
| 3b Medical, INC. | $31.85 | 2024-2025 | Luna |
| Fisher & Paykel Healthcare INC | $21.12 | 2025 | Fisher & Paykel Healthcare |
| Ambu INC. | $18.88 | 2022 | |
| Resmed Corp | $16.06 | 2024 | |
| Liquidia Technologies, INC. | $14.63 | 2025 | Yutrepia |
| Axsome Therapeutics, INC. | $13.72 | 2024 | Sunosi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kellie Grove listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.